Evidence Comparison

Omega-3 (EPA/DHA) vs Nattokinase

For heart health โ€” which one has better evidence?

๐Ÿ† Winner for heart health

Omega-3 (EPA/DHA)

Scores 45% vs 0% in evidence strength

Head-to-Head Comparison

45% Moderate
Evidence Score
0% N/A

2-4g combined EPA+DHA per day

Dosage

2000-4000 FU (fibrinolytic units) per day, equivalent to approximately 100-200mg nattokinase

With meals containing fat for optimal absorption

When

Between meals on an empty stomach for optimal absorption

Fish oil

Best Form

Enteric-coated capsules to protect enzyme from stomach acid; NSK-SD

Very Safe
Safety
Safe

$15-40/mo

Cost

$15-35/mo

3 studies

Research Cited

3 studies

Evidence for heart health

Omega-3 (EPA/DHA)

45%

Mixed evidence for cardiovascular event reduction. REDUCE-IT trial positive but used high-dose EPA only; general fish oil trials less convincing.

Nattokinase

0%

No direct evidence for this goal.

Mechanism of Action

Omega-3 (EPA/DHA)

EPA and DHA exert their effects through multiple mechanisms. They incorporate into cell membrane phospholipids, altering membrane fluidity and receptor function. EPA serves as a precursor to anti-inflammatory eicosanoids (resolvins and protectins) that actively resolve inflammation, competing with p...

Read full review โ†’

Nattokinase

Nattokinase supports cardiovascular health through several mechanisms. Its primary action is direct fibrinolysis โ€” it directly degrades fibrin, the structural protein in blood clots. Additionally, it enhances the body's own fibrinolytic system by increasing tissue plasminogen activator (tPA) activit...

Read full review โ†’

โฑ๏ธ Time to Effect

Omega-3 (EPA/DHA)

Week 1-2

No noticeable changes. Omega-3s are slowly incorporating into cell membranes.

Week 4-6

Possible reduction in joint stiffness. Blood triglycerides begin dropping if elevated.

Week 8-12

Measurable reduction in inflammatory markers (CRP). Triglyceride reduction of 15-30%.

Month 3+

Full tissue saturation. Maximum anti-inflammatory benefit achieved.

Nattokinase

Day 1-7

Fibrinolytic activity detectable in blood within hours of dosing.

Week 2-4

Blood viscosity and fibrinogen levels may decrease.

Week 4-8

Blood pressure may show modest reduction. Circulation improving.

Month 2+

Sustained fibrinolytic and cardiovascular benefits. Plaque regression possible long-term.

๐Ÿค Can You Take Both?

โœ… These can generally be taken together safely. Many people stack both for complementary effects.

However, always start one at a time so you can identify which is responsible for any effects you notice.

๐Ÿ“‹ The Bottom Line

Choose Omega-3 (EPA/DHA) if:

  • โœ“ individuals with elevated triglycerides
  • โœ“ those with high inflammatory markers
  • โœ“ people with low fish intake

Choose Nattokinase if:

  • โœ“ individuals concerned about cardiovascular health
  • โœ“ those with a family history of blood clots
  • โœ“ people with mildly elevated blood pressure

๐Ÿ“š Key Studies

Omega-3 (EPA/DHA)

Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Adviso...

Circulation (2019)

DOI โ†—

Effects of omega-3 fatty acids on inflammatory markers: A systematic review and ...

Clinical Nutrition (2022)

DOI โ†—

Nattokinase

Nattokinase: a promising alternative in prevention and treatment of cardiovascul...

Food Science and Biotechnology (2017)

DOI โ†—

A single-arm pilot study of nattokinase in reducing progression of subclinical a...

Journal of Atherosclerosis and Thrombosis (2015)

DOI โ†—
Medical Disclaimer: This comparison is based on published research for educational purposes only. Individual responses vary. Always consult a healthcare professional before starting any supplement regimen.